Steven G Widen

Title: Innovations of Steven G Widen in DNA Aptamers

Introduction

Steven G Widen is an accomplished inventor based in Galveston, TX (US). He has made significant contributions to the field of molecular biology, particularly in the development of DNA aptamers. With a total of 2 patents, his work focuses on high-affinity ligands that can bind to specific protein targets, which has important implications for therapeutic applications.

Latest Patents

Widen's latest patents include the invention of single-stranded DNA aptamers that bind to NF-kB/RelA. These DNA aptamers are chemically stable and reproducible molecules selected through genetic enrichment techniques. They have the potential to serve as affinity reagents and therapeutic drugs that can influence the actions of target proteins. NF-kB is a crucial mediator of the innate immune response and plays a significant role in tissue inflammation. Widen's invention represents the first identification of single-stranded DNA aptamers that specifically recognize NF-kB RelA. The aptamers bind to various distinct regions of RelA, which may help antagonize its DNA binding, visualize its location in tissues, or quantitatively measure its activated state.

Career Highlights

Widen is affiliated with The University of Texas System, where he continues to advance research in the field of DNA aptamers. His innovative work has garnered attention for its potential applications in medical therapies and diagnostics.

Collaborations

Some of Widen's notable coworkers include Thomas G Wood and Allan R Brasier, who have contributed to his research endeavors.

Conclusion

Steven G Widen's contributions to the field of DNA aptamers highlight the importance of innovation in addressing complex biological challenges. His work not only advances scientific understanding but also opens new avenues for therapeutic interventions.